Orin Hirschman 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-11 7:15 pm Sale | 2021-01-04 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Orin Hirschman | 5,833 4.990% | -254 (-4.17%) | Filing |
| 2020-02-13 3:16 pm Purchase | 2020-02-07 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Orin Hirschman | 6,087 9.470% | 6,087 (New Position) | Filing |